Sante Technology Holdings Inc.
SNTE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 4.11 | -4.20 |
| FCF Yield | 0.00% | 0.08% | 42.42% | -3.13% |
| EV / EBITDA | -1.32 | 3.66 | -436.73 | 242.55 |
| Quality | ||||
| ROIC | 103.56% | 0.91% | 37.13% | 2.27% |
| Gross Margin | 0.00% | 100.00% | 0.00% | 42.57% |
| Cash Conversion Ratio | 0.00 | -186.03 | -13.19 | 0.00 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -65.09% | -100.00% | – |
| Free Cash Flow Growth | 0.00% | -99.71% | 237.13% | -35,075.19% |
| Safety | ||||
| Net Debt / EBITDA | 0.01 | -0.00 | 0.00 | 0.70 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.31 |
| Cash Conversion Cycle | -51.85 | 365.00 | 0.00 | 1,870.90 |